Tineke Kleinhout‐Vliek
Biographic Data
| ID | 6676498 |
|---|---|
| NAME | Tineke Kleinhout‐Vliek |
| GIVEN NAMES | Tineke |
| FAMILY NAME | Kleinhout‐Vliek |
| SIGNATURE | VLIEK T K |
| AFFILIATIONS | University College Dublin |
| ORCID | 0000-0002-2292-8737 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
The pharmaceutical commons: Conceptual clarifications, a practice example, and a research agenda
Recent technological developments in the pharmaceutical sector have fuelled rapid price increases of advanced therapies, but they have also triggered renewed efforts around developing alternative modes of organizing pharmaceutical research and deployment. Examples include patient- and clinician-driven innovation, hospital-based manufacturing, and drug repurposing. While these developments offer a seam of fresh scholarship in the sociology of phar…
Promises past and future - Gene therapy and the actualisation of future expectations
Together for the greater goods: Legitimising social innovation in the pharmaceutical field
Social innovation initiatives in the pharmaceutical field seek alternative, collaborative ways to address problems with availability and affordability of medicines. However, these experimental initiatives require legitimacy. Formulating goals is a way of creating and contesting legitimacy, also for social innovation initiatives, yet has not been studied in this context. Based on document analysis (policy reports, news articles and websites) and s…
Implementing pharmaceutical track-and-trace systems: A realist review
INTRODUCTION: One way to prevent falsified medical products from entering the regulated pharmaceutical supply chain is to implement a pharmaceutical track-and-trace system (PTTS). Such systems in the most extensive versions generally mandate a scan at every point of contact with the medical product: from the point of entry to dispensation. There have been several attempts to implement such systems; for example, a 'full' PTTS in Turkey and the mor…
In the works: Patient and public involvement and engagement in healthcare decision‐making
In the September 2019 Special Issue of Health Expectations on Patient and Public Involvement and Engagement (PPIE) initiatives, Hickey and Chambers1 highlighted ‘the importance of [...] promoting PPIE across all areas of health and social care both nationally and internationally’ (p. 607). This resonates with the widespread recognition of PPIE's potential to improve the quality of decision-making and increase fairness, responsiveness and legitima…
No prominent works on this page.
Implementing pharmaceutical track-and-trace systems: A realist review
INTRODUCTION: One way to prevent falsified medical products from entering the regulated pharmaceutical supply chain is to implement a pharmaceutical track-and-trace system (PTTS). Such systems in the most extensive versions generally mandate a scan at every point of contact with the medical product: from the point of entry to dispensation. There have been several attempts to implement such systems; for example, a 'full' PTTS in Turkey and the mor…
In the works: Patient and public involvement and engagement in healthcare decision‐making
In the September 2019 Special Issue of Health Expectations on Patient and Public Involvement and Engagement (PPIE) initiatives, Hickey and Chambers1 highlighted ‘the importance of [...] promoting PPIE across all areas of health and social care both nationally and internationally’ (p. 607). This resonates with the widespread recognition of PPIE's potential to improve the quality of decision-making and increase fairness, responsiveness and legitima…
Together for the greater goods: Legitimising social innovation in the pharmaceutical field
Social innovation initiatives in the pharmaceutical field seek alternative, collaborative ways to address problems with availability and affordability of medicines. However, these experimental initiatives require legitimacy. Formulating goals is a way of creating and contesting legitimacy, also for social innovation initiatives, yet has not been studied in this context. Based on document analysis (policy reports, news articles and websites) and s…
The pharmaceutical commons: Conceptual clarifications, a practice example, and a research agenda
Recent technological developments in the pharmaceutical sector have fuelled rapid price increases of advanced therapies, but they have also triggered renewed efforts around developing alternative modes of organizing pharmaceutical research and deployment. Examples include patient- and clinician-driven innovation, hospital-based manufacturing, and drug repurposing. While these developments offer a seam of fresh scholarship in the sociology of phar…
Promises past and future - Gene therapy and the actualisation of future expectations
Biomedical Ethics and Regulation (2 works) · Business (2 works) · CLARITY (2 works) · Pharmaceutical Economics and Policy (2 works) · Political science (2 works) · Sociology (2 works) · Commerce (1 works) · Commons (1 works) · Computer Science (1 works) · Conceptual framework (1 works)